-
Timken Q2 adjusted EPS $1.83, up 29% YoY; raises 2026 adjusted EPS outlook to $6.05-$6.35
Sales $1.26B, up 7.5% YoY; organic sales up 4.4%. Adjusted EBITDA margin 19.6% vs 17.7% last year.
-
Timken Q1 sales up 8% to $1.23B; raises 2026 EPS guidance to $4.70-$5.20
Diluted EPS $1.40 vs $1.11 last year; adjusted EPS $1.67 vs $1.40.
-
Timken authorizes buyback of up to 10M shares, replacing prior plan expiring Feb 2026
Board approved 2026 Share Purchase Plan on Feb 13, effective March 1, 2026, for up to 10 million common shares.
-
Timken Q4 sales up 3.5% to $1.11B; adj EPS $1.14; FY2025 adj EPS $5.33; guides FY2026 adj EPS $5.50-$6.00
Q4 2025 net sales $1.11B (+3.5% YoY); organic sales +1.3%; diluted EPS $0.89, adjusted EPS $1.14.
-
Timken Q3 2025 sales up 2.7% to $1.16B; adjusted EPS $1.37, up 11.4% YoY
Diluted EPS $0.99 (down 14.7% YoY); adjusted EPS $1.37 (up 11.4% from $1.23).
-
Timken appoints Lucian Boldea as President & CEO effective Sept 1, 2025
Lucian Boldea, 54, previously led Honeywell's Industrial Automation segment since Jan 2024, will become President & CEO.
-
Timken appoints Michael Discenza CFO, replacing Philip Fracassa departing Sept 5, 2025
Michael A. Discenza named CFO effective Aug 14, 2025, succeeding Philip D. Fracassa who departs Sept 5 for another opportunity.
-
Timken Q2 2025 EPS $1.12, adj. EPS $1.42; lowers FY25 guidance high-end
Sales $1.17B, down 0.8% YoY; organic sales down 2.5%.
-
Timken Q1 sales down 4.2% to $1.14B; FY2025 EPS guidance cut on tariff impact
Sales $1.14B, -4.2% YoY; diluted EPS $1.11 (adj. $1.40) vs $1.46 ($1.77) last year.
-
Timken CEO Tarak Mehta departs; former CEO Richard Kyle returns as interim
Tarak Mehta and Timken mutually agreed to his departure as President and CEO, effective March 31, 2025; he also left the Board.
-
Timken Q4 net income up to $1.01 EPS; adj EPS $1.16; EVP Coughlin to retire Dec 2025
Q4 sales $1.07B (-1.6% YoY); diluted EPS $1.01 (up from $0.83); adj EPS $1.16 (down from $1.37).
-
Timken Q3 adjusted EPS $1.23 vs $1.55 YoY; lowers FY2024 EPS outlook to $5.55-$5.65
Q3 sales $1.13B, down 1.4% YoY; organic sales down 2.9%.
-
Timken Q2 2024: sales $1.18B (-7.1%), EPS $1.36; FY2024 EPS outlook $5.00-$5.20
Net income $96.2M ($1.36 EPS) vs $125.2M ($1.73) YoY; adjusted EPS $1.63 vs $2.01.
-
Timken sells 5.0M TIL shares for >$230M; ownership drops to 51.05%
Gross proceeds over $230M from sale of 5.0M shares of Timken India Limited.
-
Timken Q1 sales $1.19B (-5.7% YoY), GAAP EPS $1.46; raises FY2024 guidance
Net income $103.5M vs $122.3M YoY; adjusted net income $125.7M or $1.77 adjusted EPS.
-
Timken CEO Richard Kyle to retire; Tarak Mehta named successor effective Sept 5, 2024
Richard G. Kyle notified company of retirement on March 26, 2024; will leave as CEO on Sept 5, 2024.
-
Timken Q4 EPS $0.83 ($1.37 adjusted); record FY 2023 sales $4.8B; 2024 guidance softer
Q4 2023 sales $1.09B (+0.9% YoY); net income $58.7M ($0.83 diluted EPS) vs $97.2M ($1.32) prior year.
-
Timken Q3 adjusted EPS $1.55 on sales $1.14B; updates 2023 outlook
Sales $1.14B, up 0.6% YoY; EPS $1.23, adjusted EPS $1.55.
-
Timken Q2 2023: record sales $1.27B, adj EPS $2.01; updates FY adj EPS guidance to $6.90-$7.30
Record Q2 sales $1.27B (+10.3% YoY); net income $125.2M ($1.73 EPS), adjusted net income $146.1M ($2.01 EPS).
-
Timken sells 7.6M shares of Timken India for ~$288M; ownership drops to 57.7%
Gross proceeds of ~$288 million from sale, reducing ownership from 67.8% to 57.7%.
-
Timken Q1 record sales $1.26B, adj EPS $2.09; raises FY23 outlook
Record Q1 sales of $1.26B, up 12% total and 11% organically YoY.
-
Timken Q4 sales $1.08B, EPS $1.32; record FY22 adj. EPS $6.02; FY23 guidance $6.50-$7.10
Q4 sales $1.08B (+7.4% total, +10.2% organic); EPS $1.32; adjusted EPS $1.22 (Q4 record).
-
Timken Q3 adj EPS $1.52 beats; raises FY22 outlook; announces GGB Bearings acquisition
Q3 sales $1.14B (+9.6% total, +13.6% organic); GAAP EPS $1.18, adj EPS $1.52 (record Q3).
-
Timken reports record Q2 sales $1.15B, adjusted EPS $1.67, raises FY2022 guidance
Record Q2 sales $1.15B, up 8.5% YoY (organic +11%), led by industrial distribution and off-highway.
-
Timken posts record Q1 sales $1.125B, adjusted EPS $1.61; acquires Spinea
Record Q1 sales $1.125B (+9.7% YoY); GAAP EPS $1.56, adjusted EPS $1.61 (record quarterly).
-
Timken reports record FY21 EPS $4.79; Q4 sales $1.01B, +13%
Q4 sales $1.01B (+13% YoY); GAAP EPS $0.82, adjusted EPS $0.78 (down from $0.84).
-
Timken Q3 2021 sales up 16% to $1.04B; adjusted EPS $1.18, a Q3 record
Q3 sales $1.04B (+16% YoY); GAAP EPS $1.14; adjusted EPS $1.18.
-
Timken posts record Q2 sales of $1.06B (+32%); GAAP EPS $1.36, adjusted $1.37
Record revenue $1.06B, up 32% YoY; net income $104.8M vs $61.9M last year.